Jeff Kurkewich, senior scientist on the genomic team at Delfi Diagnostics, works to extract DNA from tumor samples in Development Lab 1 to improve the assay. Delfi uses machine learning (artificial intelligence) algorithms to analyze blood samples and determine whether patients have cancer. — The Baltimore Sun/TNS
BALTIMORE: Cervical cancer, like many illnesses, is treatable if it’s caught early, but each year millions of women miss out on getting routine Pap smear screening for the disease, which kills a disproportionate number of Black women.
During the pandemic, cervical cancer screening rates got even worse, especially for lower-income women and women of racial and ethnic minority groups.
Already a subscriber? Log in.
Subscribe now and receive free sooka plan for 1 month. T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
